• Publications
  • Influence

Claim Your Author Page
Ensure your research is discoverable on Semantic Scholar. Claiming your author page allows you to personalize the information displayed and manage publications (all current information on this profile has been aggregated automatically from publisher and metadata sources).
  • Katherine Stemke-Hale, Ana María González-Angulo, +19 authors Bryan T. J. Hennessy
  • Biology, Medicine
  • Cancer research
  • 2008 (First Publication: 1 August 2008)
  • Phosphatidylinositol 3-kinase (PI3K)/AKT pathway aberrations are common in cancer. By applying mass spectroscopy-based sequencing and reverse-phase protein arrays to 547 human breast cancers and 41Continue Reading
    The human epidermal growth factor receptor (HER-2) oncogene encodes a transmembrane tyrosine kinase receptor that has evolved as a major classifier of invasive breast cancer and target of therapy forContinue Reading
  • Rita Nanda, Laura Quan Man Chow, +9 authors Laurence Buisseret
  • Medicine
  • Journal of clinical oncology : official journal…
  • 2016 (First Publication: 27 September 2016)
  • PURPOSE Immune checkpoint inhibition has been demonstrated to be an effective anticancer strategy. Several lines of evidence support the study of immunotherapy in triple-negative breast cancerContinue Reading
  • Oleg Gluz, Cornelia Liedtke, Nina Gottschalk, Lajos Pusztai, Ulrike Anneliese Nitz, Nadia Harbeck
  • Medicine
  • Annals of oncology : official journal of the…
  • 2009 (First Publication: 1 December 2009)
  • Triple-negative breast cancer (TNBC) is defined by a lack of expression of both estrogen and progesterone receptor as well as human epidermal growth factor receptor 2. It is characterized by distinctContinue Reading
  • Manfred Kaufmann, Gunter von Minckwitz, +16 authors Lajos Pusztai
  • Medicine
  • Annals of Surgical Oncology
  • 2011 (First Publication: 1 May 2012)
  • The use of neoadjuvant systemic therapy (NST) for the treatment of primary breast cancer has constantly increased, especially in trials of new therapeutic regimens. In the 1980 s, NST was shown toContinue Reading
  • Kurt A. Schalper, Vamsidhar Velcheti, +4 authors David L. Rimm
  • Biology, Medicine
  • Clinical cancer research : an official journal of…
  • 2014 (First Publication: 15 May 2014)
  • PURPOSE Blockade of the PD-1/PD-L1 axis emerged as a promising new therapeutic option for cancer that has resulted in lasting responses in metastatic renal, lung carcinomas, and melanomas. TumorContinue Reading